Robert Gerwien is a seasoned biostatistician with extensive experience in clinical trials, statistical analysis, and regulatory submissions. Currently serving as a Senior Biostatistician at Actalent for Immunocore LLC, Robert leads statistical efforts on Phase I-III clinical trials in oncology and develops analysis plans. Previous roles include Principal Biostatistician at Pear Therapeutics, where statistical support was provided for 510k submissions, and Senior Biostatistician at HealthTell, focusing on algorithms for autoimmune disease biomarkers. Additional experience includes significant contributions as a Principal Statistician at both Quanticate and Tethys Bioscience, managing projects and developing predictive models in various therapeutic areas. Robert holds a Ph.D. in Biological Sciences from Rutgers University and a BS in Biology from Fairfield University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices